Missouri · Senate Bill 1264 · 2026 Regular Session (103rd General Assembly)

Removes the expiration date on certain provisions relating to gender transition

  1. Introduced Dec 1, 2025
  2. In committee Jan 27, 2026
  3. Died  
  4. Passed the House  
  5. To the governor  
  6. Became law  

What it does

The legislature's own summary of the bill, or its official long title.

SB 1264 - Currently, the prohibition on the prescription or administration of cross-sex hormones or puberty-blocking drugs for the purpose of a gender transition for persons under 18 years of age expires on August 28, 2027. This act removes that expiration date. This act is identical to a provision in SB 861 (2026), SB 249 (2025), HCS#2/SS#2/SCS/SB 10 (2025), SB 26 (2025), SB 493 (2025), SB 1185 (2024), SB 726…

Read the full title (104 words)

SB 1264 - Currently, the prohibition on the prescription or administration of cross-sex hormones or puberty-blocking drugs for the purpose of a gender transition for persons under 18 years of age expires on August 28, 2027. This act removes that expiration date. This act is identical to a provision in SB 861 (2026), SB 249 (2025), HCS#2/SS#2/SCS/SB 10 (2025), SB 26 (2025), SB 493 (2025), SB 1185 (2024), SB 726 (2024), and SB 776 (2024), substantially similar to HCS/HBs 2033, 1608, 1672, & 1854 (2026), SB 1200 (2026), and SB 75 (2025), and similar to provisions in HCS/HBs 1520, 1519, 2355, and 2357 (2024).

Every action

3 steps, oldest first, as the legislature records them.

  1. SenatePrefiled
  2. SenateS First Read
  3. CommitteeSecond Read and Referred S Families, Seniors and Health Committee · Senate Families, Seniors and Health

Roll calls

No recorded votes on this bill yet.

Sponsors

The member who introduced it.

From Missouri's official records (www.senate.mo.gov), checked Nov 14, 2026. Text links go to the official versions; LegiList does not copy bill text.